VATS Pleurodesis: Procedure, Recovery, and Life After

VATS pleurodesis is a minimally invasive surgical procedure that seals the two layers of tissue lining the lungs together, eliminating the space where air or fluid can accumulate and cause a collapsed lung or persistent effusion. It is one of the most effective interventions for preventing recurrent spontaneous pneumothorax and for managing malignant pleural effusions that keep refilling after drainage. Talc-based pleurodesis, which remains the most widely used approach, achieves success rates between roughly 80% and 95% depending on the condition being treated and the patient’s overall health. But the procedure, the recovery timeline, and the trade-offs that follow deserve a closer look than those headline numbers provide.

Who Needs VATS Pleurodesis

The two most common reasons surgeons recommend VATS pleurodesis are recurrent spontaneous pneumothorax and malignant pleural effusion. A spontaneous pneumothorax is a collapsed lung that happens without an obvious external cause, often in young, tall, thin individuals. After a first episode, many patients are watched or treated with simple drainage. After a second episode on the same side, or after a first episode with certain risk factors like a persistent air leak, pleurodesis becomes the standard recommendation to prevent it from happening again.

Malignant pleural effusions are a different problem entirely. Cancer cells spread to the lining around the lung and cause fluid to build up, making it progressively harder to breathe. Draining the fluid provides relief, but it returns. Pleurodesis aims to fuse the lung lining together so the fluid has nowhere to collect. The alternative for these patients is an indwelling pleural catheter, a small tube left in place that the patient or a caregiver drains at home. Pleurodesis offers a better chance of rapid and complete resolution but requires a hospital stay and is more invasive, while the catheter is less invasive but involves ongoing drainage for weeks or months in many patients. Symptom relief, quality of life, and costs end up comparable between the two approaches.¹

What Happens During the Procedure

VATS stands for video-assisted thoracoscopic surgery. Rather than opening the chest through a large incision, the surgeon makes one to three small incisions between the ribs and inserts a camera and instruments. You are under general anesthesia, and the lung on the operated side is usually deflated so the surgeon can see and work inside the chest cavity. In some centers, a nonintubated approach using sedation and regional anesthesia is used instead, and research in patients with malignant effusions suggests this may lead to faster early improvement in physical function and breathlessness compared to the traditional intubated approach.²

The actual pleurodesis can be achieved through chemical or mechanical means, and the choice depends on the underlying problem. For malignant effusions, the surgeon typically insufflates sterile talc powder directly onto the pleural surfaces under camera guidance. Talc triggers an intense inflammatory reaction between the two layers of tissue lining the lung, leading to swelling, cellular proliferation, and eventually fibrosis that glues the surfaces together. The evidence strongly supports talc as the most effective chemical agent available, outperforming alternatives like bleomycin and doxycycline.³

For spontaneous pneumothorax, the surgeon usually also addresses the source of the air leak, often small blisters called blebs on the lung surface, by stapling them off. Pleurodesis is then performed to prevent future episodes. The mechanical approaches include pleural abrasion, where the inner lining of the chest wall is physically roughened with a gauze pad or similar instrument to provoke scarring, and partial pleurectomy, where a strip of the parietal pleura is surgically removed. Both create inflammation that fuses the lung to the chest wall. Chemical pleurodesis with talc can also be used for pneumothorax, though the evidence base is strongest for effusions.

Pleurectomy Versus Abrasion

Whether to strip part of the pleura or simply roughen it has been debated for years. A single-center study found that patients who underwent apical pleurectomy had significantly fewer recurrences than those who had pleural abrasion alone, with recurrence in about 1 out of 73 pleurectomy patients compared to 8 out of 34 abrasion patients.⁴ That looks like a clear win for pleurectomy, but the picture gets murkier when you pool all the available data. A meta-analysis combining multiple studies found no statistically significant difference in pneumothorax recurrence between the two techniques, though pleural abrasion was associated with shorter hospital stays, shorter chest tube duration, shorter operative time, and less blood loss.⁵

The trade-off is essentially this: pleurectomy may be more thorough at preventing recurrence in certain settings, but it is a more involved procedure with a somewhat longer recovery. As we will see, pleurectomy also appears to carry a higher risk of long-term chest pain and abnormal sensations. Most surgeons make the decision based on the individual case, including how severe the pneumothorax was, how much diseased tissue they find during the operation, and whether the patient has had previous episodes.

Single-Port Versus Multi-Port VATS

A growing number of thoracic surgeons now perform VATS through a single incision rather than the traditional two or three. Data from a multicenter randomized trial comparing single-port to multi-port VATS found no meaningful difference in hospital pain levels or outcomes, but in the months after discharge, patients who had single-port surgery reported lower pain scores for the first three months and better physical function lasting up to a year.⁶ That trial studied lung cancer patients, not pleurodesis specifically, but the port-site pain mechanisms are similar. Fewer incisions between the ribs means fewer intercostal nerves potentially irritated or damaged, which matters a great deal once you are home and trying to get back to normal life.

Managing Pain After Surgery

Pain control is a central concern both during hospitalization and in the weeks that follow. The incisions themselves are small, but the procedure involves working between ribs, and the intercostal nerves that run along the underside of each rib are easily irritated. The inflammatory reaction from pleurodesis adds its own layer of discomfort, particularly with talc, which provokes significant chest wall inflammation by design.

Surgeons and anesthesiologists have several regional techniques to address this. Intercostal nerve blocks, where local anesthetic is injected around the nerves near the incision sites, are one of the most common. Thoracic epidural analgesia, a continuous infusion of pain medication into the space around the spinal cord, is another well-established option. A study of over 200 patients who had pneumothorax surgery found that intercostal nerve blocks and epidural analgesia produced similar pain scores, though patients with nerve blocks were more mobile in the first few days and had a shorter hospital stay, while epidural patients needed fewer opioids on the day of surgery and the first day after.⁷

Newer techniques like serratus anterior plane blocks, where anesthetic is deposited in the tissue plane over the rib cage, have also shown promise. A randomized trial in patients undergoing VATS lobectomy found that continuous serratus blocks, intercostal nerve blocks, and a combination of both all maintained acceptable pain levels throughout recovery.⁸ The practical takeaway for patients is that multiple effective options exist, and it is worth asking your surgical team which approach they use and why.

The Hospital Stay and Chest Tubes

After VATS pleurodesis, you will wake up with a chest tube, a plastic tube running from inside your chest out through one of the incision sites and connected to a drainage system. The tube serves two purposes: it drains any residual fluid or blood, and it allows the medical team to monitor for ongoing air leaks. How long the tube stays in depends on what comes out of it.

For pneumothorax patients, the key milestone is cessation of the air leak. Some centers remove the chest tube as soon as the air leak stops, while others keep it in for a fixed period even after the leak resolves, often to ensure the lung remains fully expanded. A systematic review examining early versus late chest tube removal after pneumothorax surgery found that early removal, defined as pulling the tube once the air leak stops, is increasingly being studied as a way to shorten hospital stays without increasing complications.⁹

Most VATS pleurodesis patients spend two to five days in the hospital, though the range varies widely. Patients undergoing pleurodesis for malignant effusions who are already hospitalized tend to have longer stays, averaging over nine days in one study, while outpatients who receive indwelling pleural catheters may go home in under two days.¹⁰ In the intercostal nerve block study mentioned earlier, median length of stay was three to four days for pneumothorax patients.⁷

Occasionally, an air leak persists for days or even weeks after surgery. Persistent air leaks are a recognized complication that can significantly extend hospitalization. When conservative management fails, options include additional chemical pleurodesis through the chest tube, autologous blood patch pleurodesis (injecting your own blood into the pleural space to seal the leak), or repeat thoracoscopy to find and seal the leak directly.¹¹ Thoracoscopic re-intervention for persistent leaks that do not respond to conservative management has been shown to achieve complete lung re-expansion, with chest tubes typically removable within three to four days afterward.¹²

Chronic Pain and Abnormal Sensations

This is the part of the conversation that often does not get enough attention before surgery. While most patients recover well, a meaningful minority develop long-lasting chest pain or unusual sensations that persist for months or years. The numbers vary across studies, partly because of different definitions, follow-up periods, and surgical techniques.

One study following patients for a median of nearly six years after VATS for spontaneous pneumothorax found that about 8% developed chronic chest pain and 22% developed chronic chest paresthesia, a term for numbness, tingling, or other abnormal sensations. Only a tiny fraction, about half a percent, needed regular painkillers. Both chronic pain and paresthesia were independently linked to having had a partial pleurectomy or pleural abrasion (as opposed to bleb resection alone) and to longer postoperative chest tube duration. Larger-diameter chest tubes also increased the risk of paresthesia.¹³

Another study, with a median follow-up of about five years, reported that roughly a third of patients had some degree of chronic complaints after VATS for pneumothorax. Most described the pain as mild, scoring under 20 on a 0-to-100 scale, and the most common description was sharp and piercing in the area of the trocar incisions. Around 10% reported shoulder pain on the operated side. Patients who had pleurectomy were more likely to report chronic pain than those who had mechanical pleurodesis alone, though the difference did not reach statistical significance in that study.¹⁴

It is worth putting these numbers in context. Chronic postsurgical pain is a recognized phenomenon after virtually any operation, and VATS compares favorably to open thoracotomy. A prospective cohort study found that uniportal VATS patients had a lower incidence of chronic pain at three months compared to patients who had open thoracotomy, and when pain did occur it tended to be less severe and less likely to have neuropathic characteristics.¹⁵ So while chronic discomfort after VATS pleurodesis is real and should be discussed honestly, the minimally invasive approach does reduce both the frequency and severity compared to more invasive chest surgery.

Long-Term Recurrence Rates

The primary purpose of pleurodesis is to prevent the problem from coming back, and the long-term data here are reassuring. A study tracking patients after VATS for first-time and recurrent spontaneous pneumothorax found an overall long-term recurrence rate of about 5%. Critically, every patient who experienced a recurrence was one who had not received pleurodesis during their initial VATS procedure. In other words, among those who did have pleurodesis performed, the recurrence rate was essentially zero in that cohort.¹⁶

Recurrence does still happen in some patients, though, and it can occur years later. A case report documented a recurrent pneumothorax six years after VATS pleurectomy, with the finding that a new layer of pleural tissue, called neopleura, had formed over the area where the original pleura had been stripped. This regeneration is rare, but it illustrates that the body’s capacity to heal can occasionally work against the intent of the procedure.¹⁷

Lung Function After Pleurodesis

A common worry before the procedure is whether fusing the lung to the chest wall will restrict breathing capacity. The inflammatory scarring does physically bind the two surfaces together, and it is reasonable to wonder whether that limits how well the lung can expand. The evidence is reassuring for most patients. A long-term follow-up study of patients who had thoracoscopic talc pleurodesis for spontaneous pneumothorax found that those with successful pleurodesis had a median forced vital capacity of 102% of predicted and a median total lung capacity of 99% of predicted, essentially normal values. The study noted that these results held in patients who did not smoke.¹⁸

This makes physiological sense. The lung does not need to slide freely against the chest wall in order to expand. Once the two surfaces are fused, the lung still expands and contracts with the rib cage, just without the thin layer of lubricating fluid between them. In practice, the vast majority of patients return to their previous level of physical activity without noticing any breathing limitation. Patients with already-compromised lung function from conditions like COPD or extensive cancer involvement are the ones most likely to notice changes, but those patients typically would not be offered pleurodesis unless the benefit of preventing recurrent effusion or pneumothorax clearly outweighed the risk.

Flying, Diving, and Activity Restrictions

Air travel is a frequent concern because cabin pressure changes can theoretically worsen a pneumothorax. After successful pleurodesis, the pleural space is obliterated, meaning there is no free space for air to expand into. Most guidelines consider flying safe once recovery from surgery is complete, typically a few weeks out, and the surgeon has confirmed on imaging that the lung is fully expanded with no residual air collections.

Scuba diving is treated much more cautiously. A history of spontaneous pneumothorax is generally considered an absolute contraindication for scuba diving and professional flying unless bilateral surgical pleurectomy has been performed. Even after successful pleurodesis on one side, the concern is that the other lung could also develop a pneumothorax at depth, which could be fatal underwater. Only bilateral pleurectomy reduces the recurrence risk enough for some aviation and diving authorities to grant a waiver.¹⁷ If diving matters to you, this is a conversation to have with your surgeon before the procedure, because the choice between pleurectomy and chemical pleurodesis could affect your eligibility down the line.

For everyday exercise, most patients can return to full activity within four to six weeks. The incision sites need time to heal, and the pleurodesis itself needs time to mature into firm scarring. Surgeons typically advise avoiding heavy lifting and strenuous upper-body exercise for the first few weeks, then gradually ramping up. Running, cycling, swimming, and other aerobic activities are generally fine once the surgeon clears you, and the normal lung function data described above confirm that the procedure itself should not limit your capacity.

What Happens If Pleurodesis Fails

When a pneumothorax recurs or an effusion reaccumulates after pleurodesis, repeat intervention is possible but more complex. Prior pleurodesis creates adhesions inside the chest that can make a second operation technically demanding. A study of patients who needed VATS after a failed talc pleurodesis found that the repeat thoracoscopic procedure was successfully completed in about 69% of cases. The remaining patients required conversion to an open thoracotomy, usually because dense adhesions, particularly along the mediastinal (central) part of the chest cavity, made it impossible to work safely through the camera.¹⁹

This is an underappreciated consideration when choosing a pleurodesis method the first time around. Talc creates particularly robust scarring, which is exactly what makes it effective, but it also makes re-entry harder if a second procedure is ever needed. Mechanical abrasion tends to produce less dense adhesions, which may make repeat surgery more straightforward but also carries a slightly higher recurrence risk. These are trade-offs worth discussing with your surgeon, particularly if you are young and may face decades during which a recurrence could occur.

Malignant Effusions and Quality of Life

For patients with cancer-related effusions, the goals and timeline are fundamentally different from those of a young person with a spontaneous pneumothorax. The purpose of pleurodesis here is palliative: to relieve breathlessness and avoid repeated hospital visits for drainage. The research comparing nonintubated VATS pleurodesis to the traditional intubated approach in these patients found that quality of life followed a similar trajectory in both groups overall, but early improvement in physical function, global health, and dyspnea was significantly greater in patients who underwent the nonintubated technique.²

For patients whose cancer is advanced enough that general anesthesia carries high risk, the option of performing VATS pleurodesis under sedation and regional blocks rather than full intubation is meaningful. Not every center offers this, but it is growing in availability. Whether you are a candidate for the nonintubated approach depends on the extent of the effusion, your overall fitness, and the experience of the surgical and anesthesia team. It is a reasonable question to raise with your care team, particularly if you are worried about the risks of general anesthesia.